- Izilendustat
-
- $35.00
-
2026-05-11
- CAS:1303512-02-8
- Purity: 99.95%
- Supply Ability: 10g
|
| | 1303512-02-8 Basic information |
| Product Name: | 1303512-02-8 | | Synonyms: | tert-butyl 4-((1-(4-chlorobenzyl)-3-hydroxy-2-oxo-1,2-dihydropyridin-4-yl)methyl)piperazine-1-carboxylate;1-Piperazinecarboxylic acid, 4-[[1-[(4-chlorophenyl)methyl]-1,2-dihydro-3-hydroxy-2-oxo-4-pyridinyl]methyl]-, 1,1-dimethylethyl ester;4-[1-(4-Chloro-benzyl)-3-hydroxy-2-oxo-1,2-dihydro-pyridin-4-ylmethyl]-piperazine-1-carboxylic acid tert-butyl ester;tert-butyl 4-[[1-[(4-chlorophenyl)methyl]-3-hydroxy-2-oxopyridin-4-yl]methyl]piperazine-1-carboxylate;tert-butyl 4-((1-(4-chlorobenzyl)-3-hydroxy-2-oxo-1,2-dihydr;inmmune response,HIF-PH,colitis,prolyl hydroxylase,Inhibitor,HIF-2,HIFs,Hypoxia-inducible factors,inflammatory bowel diseases,HIF/HIF Prolyl-Hydroxylase,Izilendustat,inhibit,HIF- lα;4-[(4-Boc-1-piperazinyl)methyl]-1-(4-chlorobenzyl)-3-hydroxypyridin-2(1H)-one;tert-butyl 4-({1-[(4-chlorophenyl)methyl]-3-hydroxy-2-oxo-1,2-dihydropyridin-4-yl}methyl)piperazine-1-carboxylate | | CAS: | 1303512-02-8 | | MF: | C22H28ClN3O4 | | MW: | 433.93 | | EINECS: | | | Product Categories: | | | Mol File: | 1303512-02-8.mol |  |
| | 1303512-02-8 Chemical Properties |
| Boiling point | 597.8±50.0 °C(Predicted) | | density | 1.302±0.06 g/cm3(Predicted) | | storage temp. | Store at -20°C | | solubility | DMSO : 25 mg/mL (57.61 mM; ultrasonic and warming and heat to 60°C) | | pka | 8.96±0.53(Predicted) | | form | Solid | | color | White to off-white |
| | 1303512-02-8 Usage And Synthesis |
| Uses | Izilendustat is a potent inhibitor of prolyl hydroxylase which can stabilize hypoxia inducible factor- 1 alpha (HIF- lα) and hypoxia inducible factor-2 (HIF-2). Izilendustat has the potential for researching diseases that relate to the body’s inmmune response like colitis and other inflammatory bowel diseases (extracted from patent WO2011057115A1 and WO2011057121A1)[1][1]. | | References | [1] Joseph H, et al. Prolyl hydroxylase inhibitors. Patent WO2011057115A1.
[2] Joseph H, et al. Compositions and methods for treating colitis. Patent WO2011057121A1. |
| | 1303512-02-8 Preparation Products And Raw materials |
|